Louise Frederika Kooij insider trades

Open-market stock purchases and sales by Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co NV, from SEC Form 4 filings since Jan 1, 2024.

Recent trades

DateStockTradeValue
Jul 20, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)$894K
Jul 20, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)$298K
Jul 20, 2026NAMS NewAmsterdam Pharma Co NVSold$2.1M
Jul 20, 2026NAMS NewAmsterdam Pharma Co NVSold$990K
Jul 20, 2026NAMS NewAmsterdam Pharma Co NVSold$92.4K
Jul 20, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jul 20, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVSold$1.2M
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVSold$9.2K
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
May 26, 2026NAMS NewAmsterdam Pharma Co NVSold$2.3M
May 26, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
May 26, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 28, 2026NAMS NewAmsterdam Pharma Co NVSold$1M
Jan 28, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 27, 2026NAMS NewAmsterdam Pharma Co NVSold$1.3M
Jan 27, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 26, 2026NAMS NewAmsterdam Pharma Co NVSold$1.1M
Jan 26, 2026NAMS NewAmsterdam Pharma Co NVSold$10.3K
Jan 26, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 23, 2026NAMS NewAmsterdam Pharma Co NVSold$850K
Jan 23, 2026NAMS NewAmsterdam Pharma Co NVSold$439K
Jan 23, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 7, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—

Companies traded

  • NAMS NewAmsterdam Pharma Co NV: 22 sales, last Jul 20, 2026

Get free alerts when Louise Frederika Kooij files a new trade →